4.6 Article

Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Anesthesiology

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019

Jonathan H. Chow et al.

Summary: A retrospective cohort study in multiple hospitals in the United States showed that aspirin use in COVID-19 patients may be associated with reduced risk of mechanical ventilation, ICU admission, and in-hospital mortality. Further studies are needed to confirm a causal relationship.

ANESTHESIA AND ANALGESIA (2021)

Article Surgery

Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review

Isaac Cheruiyot et al.

Summary: The study revealed that about 4% of critically ill COVID-19 patients experience arterial thrombotic events, with most patients being male, elderly, and having comorbidities. Arterial thrombosis is often symptomatic and can affect multiple arteries. The mortality rate in these patients is approximately 20%. Further investigation into the underlying mechanisms of arterial thrombosis in COVID-19 is needed to identify potential therapeutic targets.

ANNALS OF VASCULAR SURGERY (2021)

Article Medicine, General & Internal

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Carlo Salvarani et al.

Summary: This study evaluated the use of tocilizumab in hospitalized COVID-19 pneumonia patients and found no significant benefit compared to standard care. Further randomized clinical trials with blinded, placebo-controlled methods are needed to confirm these results and explore potential applications of tocilizumab in different stages of the disease.

JAMA INTERNAL MEDICINE (2021)

Article Hematology

Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis

Matthew L. Meizlish et al.

Summary: In this study of hospitalized COVID-19 patients, intermediate-dose anticoagulation and aspirin treatment were each associated with a significantly lower cumulative incidence of in-hospital death as shown by propensity score matching and multivariable regression analysis.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Multidisciplinary Sciences

Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration

Thomas F. Osborne et al.

Summary: The study found that pre-diagnosis aspirin prescription was significantly associated with decreased mortality rates for COVID-19 positive Veterans, indicating the potential benefits of aspirin for patients with COVID-19.

PLOS ONE (2021)

Article Medicine, General & Internal

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Dominic Wichmann et al.

ANNALS OF INTERNAL MEDICINE (2020)

Letter Cardiac & Cardiovascular Systems

Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19

Ishan Paranjpe et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Surgery

Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection

Franklin L. Wright et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)

Article Hematology

High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients

Jean-Francois Llitjos et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Incidence of venous thromboembolism in hospitalized patients with COVID-19

Saskia Middeldorp et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome

Marco Ranucci et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Clinical Neurology

Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study

Yanan Li et al.

STROKE AND VASCULAR NEUROLOGY (2020)

Article Medicine, General & Internal

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations

Sameer S. Kadri et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Biochemistry & Molecular Biology

Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches

Yuefei Jin et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Medicine, General & Internal

Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events A Systematic Review and Meta-analysis

Sean L. Zheng et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Medicine, General & Internal

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

J. J. McNeil et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Sensitivity Analysis in Observational Research: Introducing the E-Value

Tyler J. VanderWeele et al.

ANNALS OF INTERNAL MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

P2Y12 platelet inhibition in clinical practice

Peter Damman et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2012)

Article Pharmacology & Pharmacy

Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy

Timothy D. Warner et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)